Bill Buzzeo Bill Buzzeo

Bill Buzzeo is an authority on regulatory requirements facing today's pharmaceutical industry, specifically those involving the Prescription Drug Marketing Act (PDMA); international, federal, and state transparency and reporting requirements; and the Controlled Substances Act (CSA).

Shedding Light on “The Sunshine Act”

With the Center for Medicare & Medicaid Services (CMS) delaying implementation of a key ...

Aggregating Research Payments from Multiple CROs

Last month, the Centers for Medicare & Medicaid Services (CMS) published proposed regulations for ...

Aggregate Spend Compliance: Invest Now or Pay Later

It’s January–CMS has finally published proposed regulations further clarifying the Physician Payment Sunshine Act ...

Risk Evaluation and Mitigation Strategy (REMS)

The FDA is taking action to protect patients from harm caused by high risk ...

Regulatory Compliance: The Importance of Training the Field Sales Force

The manner in which life sciences companies interact with healthcare practitioners and healthcare organizations ...

Use Regulatory Compliance to Your Advantage

U.S. state and federal disclosure laws and the trend towards global transparency have created ...